E-LIB Suche - Ergebnisse für: Hyrossová, Petra

1

Glycosylation defects, offset by PEPCK-M, drive entosis in ..:

Hyroššová, Petra ; Aragó, Marc ; Muñoz Pinedo, Cristina...
Reproducció del document publicat a: https://doi.org/10.1038/s41419-022-05177-x. , 2022

Link: http://hdl.handle.net/24..

2

PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-de..:

Hyroššová, Petra ; Aragó, Marc ; Moreno Felici, Juan...
Reproducció del document publicat a: https://doi.org/10.1186/s40170-020-00236-3. , 2021

Link: http://hdl.handle.net/24..

3

Tumors defective in homologous recombination rely on oxidat..:

Lahiguera, Álvaro ; Hyroššová, Petra ; Figueras, Agnès...
EMBO Molecular Medicine;12. , 2020

Link: https://hdl.handle.net/1..

4

Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Canc..:

Moreno-Felici, Juan ; Hyrossová, Petra ; Aragó, Marc...
Reproducció del document publicat a: https://doi.org/10.3390/cells9010018. , 2020

Link: http://hdl.handle.net/24..

5

Tumors defective in homologous recombination rely on oxidat..:

Lahiguera, Álvaro ; Hyroššová, Petra ; Figueras, Agnès...
qt6bb8n8g5. , 2020

Link: https://escholarship.org..

6

Pharmacology and preclinical validation of a novel anticanc..:

Aragó, Marc ; Moreno Felici, Juan ; Abás Prades, Sònia...
Reproducció del document publicat a: https://doi.org/10.1016/j.biopha.2019.109601. , 2020

Link: http://hdl.handle.net/24..

7

Tumors defective in homologous recombination rely on oxidat..:

Lahiguera, Álvaro ; Hyrossová, Petra ; Figueras i Amat, Agnès...
Reproducció del document publicat a: https://doi.org/10.15252/emmm.201911217. , 2020

Link: http://hdl.handle.net/24..

8

Tumors defective in homologous recombination rely on oxidat..:

Lahiguera, Álvaro ; Hyroššová, Petra ; Figueras, Agnès...
info:eu-repo/semantics/altIdentifier/doi/10.15252/emmm.201911217. , 2020

Link: http://hdl.handle.net/10..

9

Role of the Transforming Growth Factor-β in regulating hepa..:

Soukupova, Jitka ; Malfettone, Andrea ; Hyroššová, Petra...
Reproducció del document publicat a: https://doi.org/10.1038/s41598-017-12837-y. , 2017

Link: http://hdl.handle.net/24..

10

Not to be picky: PEPCK-M ensures metabolic flexibility in c..:

Hyroššová, Petra
http://hdl.handle.net/2445/180601. , 2017

Link: http://hdl.handle.net/24..

11

Not to be picky: PEPCK-M ensures metabolic flexibility in c..:

Hyroššová, Petra
http://hdl.handle.net/10803/672607. , 2017

Link: http://hdl.handle.net/10..

12

Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) i..:

Méndez-Lucas, Andrés ; Hyroššová, Petra ; Novellasdemunt, Laura..
Reproducció del document publicat a: https://doi.org/10.1074/jbc.M114.566927. , 2014

Link: http://hdl.handle.net/24..

13

Effects of metabolic cancer therapy on tumor microenvironme..:

Petra Hyroššová ; Mirko Milošević ; Josef Škoda...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1046630/full. , 2022

Link: https://doi.org/10.3389/..

14

Glycosylation defects, offset by PEPCK-M, drive entosis in ..:

Petra Hyroššová ; Marc Aragó ; Cristina Muñoz-Pinedo...
https://doi.org/10.1038/s41419-022-05177-x. , 2022

Link: https://doi.org/10.1038/..

15

PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-de..:

Petra Hyroššová ; Marc Aragó ; Juan Moreno-Felici...
https://doi.org/10.1186/s40170-020-00236-3. , 2021

Link: https://doi.org/10.1186/..